Insulin resistance was associated with adverse clinical outcomes among patients with PCOS and normal weight undergoing ...

GLP-1 RAs are not linked to an increased risk for serious GI or hepatobiliary outcomes, compared with other diabetes medications.

The prevalence of T2D among a cohort of patients in Italy with SSc was lower than national estimates and associated with ...

Hormone replacement therapy (HRT) patches carry lower cardiovascular risk than oral HRT among women with type 2 diabetes.

Early on-treatment liver stiffness measurements predict reduced risk for liver-related events in patients with CHB receiving ...

An association exists between higher night-to-night sleep duration variation and increased risk for major cardiovascular disease events.

Providing immediate bedside hepatitis C virus (HCV) consultation at discharge from labor and delivery for women with HCV-affected pregnancies is associated with higher rates of treatment completion ...

Population aging is the largest contributor to the increasing burden of musculoskeletal (MSK) disorders in about one-third of countries.

Federal health officials have moved to close down a Miami-based organ donation agency, citing unsafe practices, missed donations and critical paperwork errors.

In children and adolescents with type 2 diabetes (T2D) or obesity, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) improve glycemic, weight, and cardiometabolic outcomes.

This patient perspective entails a first-hand experience of fatphobia and weight-inclusive health care in the clinical setting.

Dapagliflozin significantly decreases risk for new-onset type 2 diabetes mellitus following myocardial infarction regardless of glycemic status or BMI.